dpp4 and glp-1 mechanism of action GLP-1-RA DPP-4 inhibitors in the management type 2 diabetes Frontiers | Clinical Use of

Saxenda is specifically indicated for use in adults with obesity (with a body mass index BMIof 30 kg/m2 or greater) or overweight adults (a BMI of 27 kg/m2 or greater) who also have weight-related health conditions such as hypertension (high blood pressure), high cholesterol, or obstructive sleep apnea

Because c-Myc mediated miR-23a and miR-23b repression, overexpression of c-MYC can upregulate GLS, and therefore promote glutaminolysis (Gao et al., 2009) (Figure 2)

BMC Endocr Disord (2020) 20(1):177

Receptor-mediated endocytosis is a highly selective process where NPs are internalized by cells through specific interactions between ligands on the NP surface and corresponding receptors on the cell membrane (77)